Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Ribavirin oral liquid and preparation method thereof

A technology of virin oral liquid and ribavirin, which is applied in the field of ribavirin oral liquid, can solve the problems of unfavorable long-term storage and low stability, and achieve the effects of wide application range, ensuring product safety, and adjusting taste

Active Publication Date: 2015-06-10
常州康普药业有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The invention overcomes the disadvantages of low stability of ribavirin oral liquid preparations in the prior art and is unfavorable for long-term storage, and provides a ribavirin oral liquid and a preparation method thereof

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ribavirin oral liquid and preparation method thereof
  • Ribavirin oral liquid and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0015] Table 1 Components and content

[0016] Raw materials

Example 1

Example 2

Example 3

Example 4

Example 5

Ribavirin (g)

3.00

3.00

3.00

3.00

3.00

Xylitol (g)

3

3

3.5

3

4

Disodium hydrogen phosphate (g)

0.267

0.8

0.4

0.534

0.6

Menthol (g)

1

0.5

0.7

0.5

0.80

Activated carbon (g)

0.2

0.1

0.05

0.1

0.2

Propylene glycol (ml)

1

0.5

0.7

0.8

0.8

Water for injection (ml)

Add to 100ml

Add to 100ml

Add to 100ml

Add to 100ml

Add to 100ml

Taste (sweetness)

sweetness

sweetness

sweet

sweet

sweet

pH value

5.5

6.0

5.7

5.6

5.8

[0017] Such as figure 1 Shown, the preparation method of above-mentioned ribavirin oral liquid, the steps are as follows: add the water for injection of preparation total amount 80% in the pre...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of medicines, in particular relates to ribavirin oral liquid, and aims at overcoming the shortages of low stability and inconvenient long-term storage of ribavirin oral liquid preparations in the prior art. According to the technical scheme, every 1000 ribavirin oral liquid reaches 5000ml and contains 0.15kg of ribavirin, 0.15 to 0.2kg of xylitol, 13.35 to 40g of sodium hydrogen phosphate, 25 to 50g of menthol, 2.5 to 10g of activated carbon, 25 to 50ml of propylene glycol, and the balance of water for injection. The ribavirin oral liquid has the beneficial effects that the pH and related materials (impurities) in the storage period are not increased, and the product safety is ensured.

Description

technical field [0001] The invention belongs to the field of medicines, in particular to ribavirin oral liquid. Background technique [0002] Ribavirin, also known as ribavirin and ribavirin, is a broad-spectrum antiviral drug. It has the effect of inhibiting respiratory syncytial virus, influenza virus, adenovirus and other viruses. It is suitable for viral pneumonia and bronchitis caused by respiratory syncytial virus, skin herpes virus infection, etc. [0003] Ribavirin medicine can be made into various preparation forms, such as injection, tablet, oral liquid and so on. When used as an oral liquid preparation, it is often unfavorable for preservation due to its low stability. After a long period of storage, it will lead to the decomposition and failure of the effective substance for drug degradation, resulting in the failure of the drug action, thereby losing the therapeutic effect. There is still no effective solution to its stability in the prior art. Contents of ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/08A61K31/7056A61K47/10A61P31/14A61P31/16A61P11/00A61P31/22A61P17/00
Inventor 王苏南汤金春
Owner 常州康普药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com